🕊️

Shefali Jariwala's Tragic Death

Jul 1, 2025

Overview

Actress Shefali Jariwala, known for "Kaanta Laga," died suddenly at 42 after collapsing at home. Her final hours included a vitamin C drip and fasting for a religious ceremony; police are investigating the possible role of anti-ageing treatments in her death.

Timeline of Final Events

  • Shefali Jariwala collapsed between 10 and 11 PM on June 27 at her home.
  • Her husband, Parag Tyagi, rushed her to Bellevue Multispecialty Hospital, where she was declared dead on arrival.
  • Earlier that day, Shefali had taken a vitamin C IV drip.
  • She was fasting due to a Satyanarayan puja held at her home.
  • After dinner, Shefali felt uneasy and asked her husband to return home, after which she was found unresponsive.
  • The helper notified Parag of Shefali's distress, prompting immediate action.

Medical and Investigative Details

  • Police are examining links between Shefali's anti-ageing treatments and her death.
  • She had reportedly used anti-ageing infusions and oral medicines, like glutathione, for about ten years.
  • A postmortem has been completed; the final medical opinion is pending.
  • Authorities are analyzing the contents of the vitamin C drip and other medicines administered.
  • The person who gave the IV drip was summoned by police for questioning.

Industry and Social Context

  • Friends describe vitamin C drips as common in the entertainment industry, with many using them for perceived health and beauty benefits.
  • Anti-ageing treatments are viewed as a regular practice among celebrities.

Funeral and Aftermath

  • Shefali's last rites took place at Oshiwara Hindu crematorium, attended by family and close friends.
  • The home was observed to be decorated for the religious ceremony held earlier on the day of her death.

Questions / Follow-Ups

  • What is the final medical cause of Shefali Jariwala’s death?
  • Will the police investigation find a direct link between the IV drip, anti-ageing treatments, and the cardiac arrest?
  • Are there implications for the oversight of such treatments in the entertainment industry?